Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lucid Diagnostics (LUCD) Net Income towards Common Stockholders (2021 - 2025)

Lucid Diagnostics (LUCD) has disclosed Net Income towards Common Stockholders for 5 consecutive years, with -$10.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Net Income towards Common Stockholders rose 15.96% year-over-year to -$10.4 million, compared with a TTM value of -$65.8 million through Sep 2025, down 25.82%, and an annual FY2024 reading of -$53.0 million, down 0.63% over the prior year.
  • Net Income towards Common Stockholders was -$10.4 million for Q3 2025 at Lucid Diagnostics, down from -$7.9 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at -$3.7 million in Q1 2021 and bottomed at -$36.0 million in Q1 2025.
  • Average Net Income towards Common Stockholders over 5 years is -$12.9 million, with a median of -$11.5 million recorded in 2024.
  • The sharpest move saw Net Income towards Common Stockholders crashed 235.89% in 2022, then grew 28.32% in 2025.
  • Year by year, Net Income towards Common Stockholders stood at -$11.3 million in 2021, then tumbled by 32.04% to -$14.9 million in 2022, then increased by 27.45% to -$10.8 million in 2023, then dropped by 6.33% to -$11.5 million in 2024, then grew by 9.72% to -$10.4 million in 2025.
  • Business Quant data shows Net Income towards Common Stockholders for LUCD at -$10.4 million in Q3 2025, -$7.9 million in Q2 2025, and -$36.0 million in Q1 2025.